Alan C. Hartford

ORCID: 0000-0003-2273-7882
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advanced Radiotherapy Techniques
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Brain Metastases and Treatment
  • Medical Imaging Techniques and Applications
  • Radiopharmaceutical Chemistry and Applications
  • Radiation Dose and Imaging
  • Bladder and Urothelial Cancer Treatments
  • Angiogenesis and VEGF in Cancer
  • Meningioma and schwannoma management
  • Advanced MRI Techniques and Applications
  • Management of metastatic bone disease
  • Cancer, Hypoxia, and Metabolism
  • Head and Neck Cancer Studies
  • Pancreatic and Hepatic Oncology Research
  • Cancer Genomics and Diagnostics
  • Radiation Therapy and Dosimetry
  • Global Cancer Incidence and Screening
  • Advanced X-ray and CT Imaging
  • Electron Spin Resonance Studies
  • Radiomics and Machine Learning in Medical Imaging
  • Medical Imaging and Pathology Studies
  • Urinary and Genital Oncology Studies
  • Breast Cancer Treatment Studies

Queen's University
2024-2025

University of Massachusetts Boston
2025

Dartmouth–Hitchcock Medical Center
2015-2024

Cotton (United States)
2009-2024

Dartmouth Health
2022-2024

Dartmouth College
2004-2024

Dartmouth Cancer Center
2023

Nanomed (Brazil)
2023

American College of Radiology
2020

CARE Canada
2019

The Radiation Therapy Oncology Group 9804 study identified good-risk patients with ductal carcinoma in situ (DCIS), a breast cancer diagnosis found frequently mammographically detected cancers, to test the benefit of radiotherapy (RT) after breast-conserving surgery compared observation.This prospective randomized trial (1998 2006) women low- or intermediate-grade DCIS, measuring less than 2.5 cm margins ≥ 3 mm, RT observation surgery. was designed for 1,790 but closed early because lower...

10.1200/jco.2014.57.9029 article EN Journal of Clinical Oncology 2015-01-21

American College of Radiology and Society for Radiation Oncology Practice Guideline the Performance Stereotactic Radiosurgery (SRS). SRS is a safe efficacious treatment option variety benign malignant disorders involving intracranial structures selected extracranial lesions. involves high dose ionizing radiation with degree precision spatial accuracy. A quality program requires multidisciplinary team involved in patient management. Organization, appropriate staffing, careful adherence to...

10.1097/coc.0b013e31826e053d article EN American Journal of Clinical Oncology 2013-05-15

Aim/Objectives/Background: To standardize the practice of stereotactic body radiation therapy (SBRT), American College Radiology (ACR) and Society for Radiation Oncology (ASTRO) cooperatively developed parameter SBRT. SBRT is a treatment technique that delivers dose to well-defined extracranial target in 5 fractions or less usually employs higher per fraction than used conventional radiation. Methods: The ACR–ASTRO Practice Parameter Performance Stereotactic Body Therapy was revised...

10.1097/coc.0000000000000706 article EN American Journal of Clinical Oncology 2020-05-12

To our knowledge, NRG/RTOG 9804 is the only randomized trial to assess impact of whole breast irradiation (radiation therapy [RT]) versus observation (OBS) in women with good-risk ductal carcinoma situ (DCIS), following lumpectomy. Long-term results focusing on ipsilateral recurrence (IBR), primary outcome, are presented here.Eligible patients underwent lumpectomy for DCIS that was mammogram detected, size ≤ 2.5 cm, final margins ≥ 3 mm, and low or intermediate nuclear grade. Consented were...

10.1200/jco.21.01083 article EN Journal of Clinical Oncology 2021-08-18

Aim/Objectives/Background: The American College of Radiology (ACR) and the Society for Radiation Oncology (ASTRO) have jointly developed following practice parameter image-guided radiation therapy (IGRT). IGRT is that employs imaging to maximize accuracy precision throughout entire process treatment delivery with goal optimizing reliability target, while minimizing dose normal tissues. Methods: ACR–ASTRO Practice Parameter was revised according described on ACR website (“The Process...

10.1097/coc.0000000000000697 article EN American Journal of Clinical Oncology 2020-05-22

10.1016/j.prro.2024.04.027 article EN Practical Radiation Oncology 2025-01-01

Importance Although dementia is a contraindication for feeding tube placement, guidelines recommending against its use are inconsistently followed, and factors associated with unclear. Objective To describe the incidence of placement among hospitalized older adults (aged ≥65 years) their health outcomes during after hospitalization to identify tubes (ie, gastrostomy, gastrostomy-jejunostomy, jejunostomy tubes). Design, Setting, Participants This population-based retrospective cohort study...

10.1001/jamanetworkopen.2024.60780 article EN cc-by-nc-nd JAMA Network Open 2025-02-20
Coming Soon ...